| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.0054 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |